Trial · NCT00968708
Adverse events1,464
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 60 of 1,464
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diabetes mellitus | Metabolism and nutrition disorders | Placebo | 70 | 2,679 | |
| other | Diabetes mellitus | Metabolism and nutrition disorders | Alogliptin | 52 | 2,701 | |
| other | Dyslipidaemia | Metabolism and nutrition disorders | Placebo | 49 | 2,679 | |
| other | Dyslipidaemia | Metabolism and nutrition disorders | Alogliptin | 56 | 2,701 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 84 | 2,679 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Alogliptin | 79 | 2,701 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 64 | 2,679 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Alogliptin | 68 | 2,701 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo | 60 | 2,679 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Alogliptin | 54 | 2,701 | |
| other | Dizziness | Nervous system disorders | Placebo | 68 | 2,679 | |
| other | Dizziness | Nervous system disorders | Alogliptin | 81 | 2,701 | |
| other | Headache | Nervous system disorders | Placebo | 72 | 2,679 | |
| other | Headache | Nervous system disorders | Alogliptin | 69 | 2,701 | |
| other | Renal impairment | Renal and urinary disorders | Placebo | 174 | 2,679 | |
| other | Renal impairment | Renal and urinary disorders | Alogliptin | 203 | 2,701 | |
| other | Proteinuria | Renal and urinary disorders | Placebo | 107 | 2,679 | |
| other | Proteinuria | Renal and urinary disorders | Alogliptin | 103 | 2,701 | |
| other | Diabetic nephropathy | Renal and urinary disorders | Placebo | 68 | 2,679 | |
| other | Diabetic nephropathy | Renal and urinary disorders | Alogliptin | 62 | 2,701 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00968708/events?page=3